Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00382_DB01087_nanopub.RA4rBq2a4STCHpdCYcwYNB9kOzOXj7HVCJfEiJlPipuZg#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00382_DB01087 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00382_DB01087 label "DDI between Tacrine and Primaquine - The metabolism of Tacrine, a CYP1A2 substrate, may be reduced by strong CYP1A2 inhibitors such as Primaquine. Consider modifying therapy to avoid Tacrine toxicity. Monitor the efficacy and toxicity of Tacrine if Primaquine is initiated, discontinued or if the dose is changed. [drugbank_resource:DB00382_DB01087]" assertion.
- drugbank_resource:DB00382_DB01087 identifier "drugbank_resource:DB00382_DB01087" assertion.
- drugbank_resource:DB00382_DB01087 title "DDI between Tacrine and Primaquine - The metabolism of Tacrine, a CYP1A2 substrate, may be reduced by strong CYP1A2 inhibitors such as Primaquine. Consider modifying therapy to avoid Tacrine toxicity. Monitor the efficacy and toxicity of Tacrine if Primaquine is initiated, discontinued or if the dose is changed." assertion.
- drugbank:DB00382 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00382_DB01087 assertion.
- drugbank:DB01087 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00382_DB01087 assertion.